Senior insider sale
EVP, Innovative Medicine, R&D at JOHNSON & JOHNSON — senior position signals high conviction
$13.11M
53.93K shares
What this filing means
REED JOHN C plans to sell 53.93K shares of JOHNSON & JOHNSON valued at approximately $13.11M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001959173-26-001028
Officer· EVP, Innovative Medicine, R&D
Since Feb 2026
53.93K
Shares to sell
$13.11M
Approx. market value
53.93K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Options Granted - 02/15/2024
Cash
2/17/2026
21.72KOptions Granted - 02/15/2025
Cash
2/17/2026
29.93KRestricted Stock Vesting
Compensation
2/15/2026
2.28KTotal acquired53.93K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Options Granted - 02/15/2024 Cash | 21.72K | — |
2/17/2026 | Options Granted - 02/15/2025 Cash | 29.93K | — |
2/15/2026 | Restricted Stock Vesting Compensation | 2.28K | — |
| Total | 53.93K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
53.93K
Market value
$13.11M
2/17/2026
Total
Units
53.93K
Value
$13.11M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/17/2026 | 53.93K | $13.11M | NYSE | Planned |
| Total | 53.93K | $13.11M | ||